If you used a chart designed for 2.5 mg/ml on a 5 mg/ml vial and drew 20 units, you would get double
In the context of MASLD/MASH, analogous rebound phenomena would be expected: regression of achieved steatosis resolution and potential re-emergence of inflammatory activity and fibrogenic stimuli upon drug withdrawal
Neurochem Res 2000
We found that among patients with diabetes aged 66 and older, the incidence of nAMD was approximately 1 in 1,000 in those who had never used GLP-1 receptor agonists, compared to about 2 in 1,000 among those who had been exposed to these medications for at least six months, Muni said
When a peripheral nerve fiber is damaged, the portion of the axon beyond the injury point degenerates through a process called Wallerian degeneration
The result is a compound that attacks obesity from angles that dual agonists simply cannot reach